Alzheimer's Prevention Trial Expands With New $$

March 4, 2015 9:15 PM

3 0

Alzheimer's Prevention Trial Expands With New $$

Investigators on the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study -- testing the beta-amyloid scavenging drug solanezumab in clinically healthy people at elevated risk for Alzheimer's disease -- now have an extra $8 million to examine additional aspects of the disease.

The funds will support additional evaluations in a subset of A4 participants and also a complementary study of 500 individuals volunteering for the drug trial but not enrolled.

Also read: Northrop Grumman receives modification for Japanese Hawkeye contract

Read more

To category page